Hepatitis

  • Most Topular Stories

  • $1,000 Sovaldi Now Hepatitis Treatment of Choice

    Hepatitis News
    30 Jul 2014 | 10:28 am
    The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
  • Nigeria: 20 Million Infected With Hepatitis - Expert

    MedWorm: Hepatitis B
    29 Jul 2014 | 2:53 am
    [Independent]Benin -A medical expert and former Chairman of Nigerian Medical Association (NMA), Edo State chapter, Philip Ugbodaga, on Monday, declared that about 20 million (12 per cent) Nigerians are currently infected with hepatitis B and C. (Source: AllAfrica News: Health and Medicine)MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
  • What Is Viral Load?

    About.com Hepatitis: What's Hot Now
    hepatitis.guide@about.com
    30 Jul 2014 | 4:09 am
    Viral load is a measurement of the amount of virus in your blood. Most commonly, viral load is found in people with hepatitis C. Using a test called quantitative HCV RNA, the number of hepatitis viruses in the blood is determined by how much viral RNA (the virus' genetic material) is detected. There is also a viral load test for hepatitis B.
  • HCV RNA

    About.com Hepatitis: Most Popular Articles
    30 Jul 2014 | 5:02 am
    Definition of HCV RNA. Hepatitis.
  • Meet the HCV Expert

    Hepatitis Central
    The Editors at Hepatitis Central
    23 Jul 2014 | 6:45 am
    A Discussion on HCV and What You Need to Know Join patients, caregivers and support care personnel in this “Meet the HCV Expert” webinar featuring Aijaz Ahmed, MD of the University of Stanford on Monday, July 28, 2014 at 7pm Pacific Time. Dr. Ahmed is an Associate Professor of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine in Stanford, CA. His clinical focus is in hepatology, gastroenterology and liver transplantation. Register for this event at http://www.meetthehcvexpert.com/Ahmed/registration.cfm.
 
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • What Is Viral Load?

    hepatitis.guide@about.com
    30 Jul 2014 | 4:09 am
    Viral load is a measurement of the amount of virus in your blood. Most commonly, viral load is found in people with hepatitis C. Using a test called quantitative HCV RNA, the number of hepatitis viruses in the blood is determined by how much viral RNA (the virus' genetic material) is detected. There is also a viral load test for hepatitis B.
  • Microbe

    hepatitis.guide@about.com
    30 Jul 2014 | 4:09 am
    Microbe - Definition of Microbe. Hepatitis.
  • What's the Difference Between Acute and Chronic...

    hepatitis.guide@about.com
    30 Jul 2014 | 4:09 am
    Hepatitis B is a disease caused by the hepatitis B virus, and can be acute or chronic. Infection with hepatitis B virus is the leading cause of chronic hepatitis worldwide and people with chronic hepatitis B infection are at increased risk for developing liver cancer. In addition, the hepatitis B virus is the leading cause of cirrhosis in the world. Page 2.
  • Six Common Questions About Spreading Hepatitis C

    hepatitis.guide@about.com
    30 Jul 2014 | 4:09 am
    How can you get hepatitis C? Here are answers to six common questions about how hepatitis C spreads and how you can and cannot get hepatitis C.
  • What Are the Symptoms of Acute Viral Hepatitis?

    hepatitis.guide@about.com
    30 Jul 2014 | 4:09 am
    Wondering if that ache or pain could mean hepatitis? Symptoms of acute viral hepatitis are very similar, whether you have hepatitis A, hepatitis B, or hepatitis C, or other hepatitis viruses. It's hard to know which you have without the help of blood tests and a doctor. Most people don't realize they have hepatitis until they see jaundice, a symptom that makes the skin appear yellowish. However, many people don't develop jaundice. Page 2.
 
  • add this feed to my.Alltop

    Hepatitis Central

  • Meet the HCV Expert

    The Editors at Hepatitis Central
    23 Jul 2014 | 6:45 am
    A Discussion on HCV and What You Need to Know Join patients, caregivers and support care personnel in this “Meet the HCV Expert” webinar featuring Aijaz Ahmed, MD of the University of Stanford on Monday, July 28, 2014 at 7pm Pacific Time. Dr. Ahmed is an Associate Professor of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine in Stanford, CA. His clinical focus is in hepatology, gastroenterology and liver transplantation. Register for this event at http://www.meetthehcvexpert.com/Ahmed/registration.cfm.
  • Telling a Child He or She Is Infected with Hepatitis C

    Nicole Cutler L.Ac.
    22 Jul 2014 | 8:44 am
    Parenting is far from easy, a realization that crystallizes the day our children are born. When a child has Hepatitis C, the challenges seem to mount even more rapidly. Deciding when and how to explain to your child that they have this viral infection of the liver requires strength, compassion and a solidly constructed plan. Known as vertical transmission, most children are infected with Hepatitis C at birth. A mother with Hepatitis C has a 1 in 20 chance of passing the infection on to her child. The higher the mother’s viral load, the greater likelihood of vertical transmission occurring.
  • Supplemental New Drug Application Submitted to FDA by Janssen

    The Editors at Hepatitis Central
    22 Jul 2014 | 8:17 am
    ISSUE: JULY 2014 Janssen Submits Supplemental NDA For Olysio for Once-Daily Use In Combination With Sofosbuvir On May 7, Janssen announced the submission of a Supplemental New Drug Application (sNDA) to the FDA for simeprevir (Olysio), an NS3/4A hepatitis C virus (HCV) protease inhibitor, in combination with the NS5B HCV polymerase inhibitor, sofosbuvir (Sovaldi, Gilead Sciences). Janssen is seeking regulatory approval of the combination for the treatment of HCV genotype 1 infection in treatment-naive patients with advanced liver fibrosis and in null responders with all stages of liver…
  • Cured of Hepatitis C: Is There Potential to Infect Others?

    Nicole Cutler L.Ac.
    14 Jul 2014 | 8:51 am
    Those lucky enough to be cured of Hepatitis C have much to celebrate, but remain unsure of what being cured actually means. Does ‘cured’ of Hepatitis C mean that all viral particles are 100 percent absent forever, or does it mean the virus has gone into remission? More importantly, does being cured completely eliminate all chances of infecting others in the case of blood-to-blood contact? In general, we are more comfortable living in a world of absolutes than acknowledging several shades of grey. Unfortunately, the potential for infectivity following a Hepatitis C cure lies somewhere in…
  • Can This Virus Prevent Liver Transplant Rejection?

    The Editors at Hepatitis Central
    2 Jul 2014 | 8:36 am
    In a Twist, Having Hepatitis C May Prevent Liver Transplant Rejection Written by Kristen Fischer June 25, 2014 By suppressing the immune system, hepatitis C may be able to keep the body from attacking a newly transplanted organ. It turns out there’s a silver lining to having hepatitis C (HCV), an infection that can badly damage the liver. According to a new study in Science Translational Medicine, the hepatitis C virus can suppress the immune response that causes the body to reject transplanted organs as foreign invaders. Continue reading this entire article:…
  • add this feed to my.Alltop

    Hepatitis News

  • Illinois Medicaid restricts use of hepatitis drug 

    30 Jul 2014 | 3:59 pm
    … $1,000 pill to treat hepatitis C, Illinois' Medicaid program … abuse within the past year. Hepatitis C spreads today mostly among … by Gilead Sciences shows the hepatitis C medication Sovaldi. Facing ballooning … $1,000 pill to treat hepatitis C, Illinois’ Medicaid program is …
  • SLU hepatitis expert honored at White House

    30 Jul 2014 | 3:23 pm
    … during a commemoration of World Hepatitis Day. Di Bisceglie was featured … breakthrough and controversial drug for hepatitis C, Sovaldi. Di Bisceglie and … progression from the discovery of hepatitis C in the 1980s to …
  • OxySure (OXYS) Announces Corporate Update

    30 Jul 2014 | 2:20 pm
    FRISCO, TEXAS, UNITED STATES, July 30, 2014 /EINPresswire.com/ -- Frisco, Texas, USA, July 30, 2014 – OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency …
  • Ary Sarkar Celebrates Four Years of Success as Leader of the Arable Corporation

    30 Jul 2014 | 2:18 pm
    Ary Sarkar has been providing the best in biomedical technology research with the Arable Corporation since 2010. PALO ALTO, CA, USA, July 30, 2014 /EINPresswire.com/ -- Ary Sarkar founded Arable Corporation in 2010, at the same time becoming the …
  • Long Island Gamma Knife® Perfexion™ Can Treat Multiple Brain Metastases In One Session

    30 Jul 2014 | 2:18 pm
    Led by Drs. Michael Brisman and Edward Mullen, South Nassau Communities Hospital’s Gamma Knife Center is Most Experienced on Long Island ROCKVILLE CENTRE, NEW YORK, USA, July 30, 2014 /EINPresswire.com/ -- The Long Island Gamma Knife® at South Nassau …
 
  • add this feed to my.Alltop

    Hepatitis C Treatment News

  • Regulus Receives Orphan Drug Designation For RG-012, A microRNA Therapeutic For The Treatment Of Alport Syndrome

    30 Jul 2014 | 7:55 pm
    … .S. Food & Drug Administration (FDA) has granted orphan drug designation … targeting microRNA-122 for the treatment of chronic hepatitis C virus infection. Regulus… the process of discovering, developing and commercializing drugs that are safe and …
  • Will BC Cover Pricey Hep C 'Miracle' Treatment? | The Tyee

    30 Jul 2014 | 4:19 pm
    … .' Read more: Health, Hepatitis C patients in B.C. … pills of Sovaldi over a 12-week period to complete the treatment … $650 a pill. The full course of treatment costs $55 … medications are the first interferon-free drugs available outside of a clinical trial …
  • Seniors to FDA: Safety in biosimilars

    30 Jul 2014 | 3:40 pm
    … revolutionized the treatment of multiple sclerosis, HIV, hepatitis C, rheumatoid … of biosimilar medications, the fact remains that these drugs, … percent want human clinical trials to take place. … whenever new treatments are introduced. FDA officials need …
  • OxySure (OXYS) Announces Corporate Update

    30 Jul 2014 | 2:20 pm
    FRISCO, TEXAS, UNITED STATES, July 30, 2014 /EINPresswire.com/ -- Frisco, Texas, USA, July 30, 2014 – OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency …
  • Ary Sarkar Celebrates Four Years of Success as Leader of the Arable Corporation

    30 Jul 2014 | 2:18 pm
    Ary Sarkar has been providing the best in biomedical technology research with the Arable Corporation since 2010. PALO ALTO, CA, USA, July 30, 2014 /EINPresswire.com/ -- Ary Sarkar founded Arable Corporation in 2010, at the same time becoming the …
  • add this feed to my.Alltop

    Today

  • Bath time! Watch this pit bull lick baby into a fit of laughter

    Emily Wickwire
    30 Jul 2014 | 2:27 pm
    It seems that bath time for your toddler doesn't have to be such a struggle. That is, if your pet dog is willing to pitch in. Briana Figueras recorded her family's 3-year-old pit bull, Gemma, smothering her 10-month-old son, Elliott, with kisses — and the giggles that ensued are adorable. "She's crazy about him, so that's pretty typical around here," she told TODAY.com.
  • Five cases when buyer's remorse will cost you big

    Kelli B. Grant
    30 Jul 2014 | 2:03 pm
    Buyer's remorse can have serious consequences — and not just the usual symptoms of anxiety, nausea and sweaty palms.Particularly for big-ticket items, ignoring any "should I or shouldn't I?" butterflies ahead of a purchase could be an expensive mistake. Strict sellers' policies make it tough to walk away unscathed.
  • 5 things we love about H&M's fall home collection

    Amy Eley
    30 Jul 2014 | 1:33 pm
    It may be July, but H&M is already ushering in the fall season.While the popular fashion retailer is known for its affordable clothing — like a $99 wedding dress — its home collection hit U.S. stores in 2013. And with its recent debut of its fall home products, we are liking what we are seeing. Here are five things we are coveting from next season's H&M's home line:1.
  • Drink up! Three summer juices to quench your thirst

    TODAY
    30 Jul 2014 | 1:21 pm
    Nothing pairs with a hot summer day better than a cool drink, like a tasty, nutritious juice. Jenny Levison from the Atlanta restaurant "Souper Jenny" is sharing her favorite juice recipes, packed with fruits, veggies and other refreshing ingredients. Super fuel 1 cup fresh watermelon juice1/2 cup fresh pineapple juice1/2 cup fresh orange juice1/2 cup coconut water3 tbsp.
  • Better off red: Julianne Moore, daughter join fiery stars in Vogue gallery

    Kurt Schlosser
    30 Jul 2014 | 12:50 pm
    Several of the hottest entertainers on the planet also happen to have fiery heads of hair, and for that they're celebrated in a new gallery by photographer Annie Leibovitz in Vogue.Actress Julianne Moore is among the celebs whose locks get the love in the fashion mag as "the moment's reigning redheads.
  • add this feed to my.Alltop

    Hepatitis News

  • Two patients seek to launch class-action suit against Montreal hospital

    30 Jul 2014 | 5:38 pm
    Two women are trying to launch a class-action lawsuit against a Montreal-area hospital which is testing patients who underwent bariatric surgery and might have contracted HIV or hepatitis from an improperly sterilized surgical tool.
  • Illinois Medicaid restricts use of hepatitis drug

    30 Jul 2014 | 1:38 pm
    After spending an estimated $16 million this fiscal year on Sovaldi, which holds promise for a cure for the liver-damaging disease, the state agency headed by Julie Hamos approved the restrictions July 10. The rules limit the drug to sicker patients and bar it for anyone with a recent history of drug or alcohol abuse.
  • $1,000 Sovaldi Now Hepatitis Treatment of Choice

    30 Jul 2014 | 10:28 am
    The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
  • Pilot aims to tackle hepatitis C

    30 Jul 2014 | 6:24 am
    Those behind it said Cornwall was chosen because population movement was minimal which would make assessing the success of the scheme much easier.
  • 'Intensify Education On Hepatitis B'

    30 Jul 2014 | 2:11 am
    Richard Kofi Boahen THINK HEALTH, a non-governmental organisation, has called for a more coordinated and integrated approach in Ghana in the fight against Hepatitis B in view of the devastating effects of the disease on the socio-economic fortunes of the country.
 
  • add this feed to my.Alltop

    Hepatitis Blog

  • Another Reason for Hepatitis A Vaccines – Your Restaurant Remains Closed

    Bill Marler
    19 Jul 2014 | 5:09 am
    Tortilla Marissa’s, a Mexican restaurant in Fort Collins, CO, will not reopen until August 9 because of the Hepatitis A scare that the restaurant faced at the end of June, according to the Coloradoan. The Larimer County Health Department has advised the owners to keep the restaurant closed that long due to the virus’ relatively long incubation period, which averages 28 days but can last up to 50 days in some cases. The restaurant originally closed on June 27, a day after an employee tested positive for the virus, which has a high risk of being spread when an infected person handles…
  • Another Hepatitis A Scare: Tortilla Marissa’s Restaurant Worker

    Bill Marler
    28 Jun 2014 | 7:46 am
    The Larimer County Department of Health and Environment is advising the public about a possible exposure to hepatitis A virus at the Tortilla Marissa’s restaurant located at 2635 S. College Avenue in Fort Collins. A food worker employed at Tortilla Marissa has tested positive for hepatitis A, a disease that might be passed to others through food directly handled by the employee before any symptoms appeared.  The restaurant is cooperating fully in the investigation and has agreed to voluntarily close until approved by the Department to reopen.  The risk of transmission to others occurred…
  • 2300 Hepatitis A Vaccines Linked to Springfield Red Robin

    Bill Marler
    25 May 2014 | 7:12 pm
    KSPR’s Jeff Phillips reports that Springfield Health officials have now administered more than 2,300 doses of the hepatitis A vaccine. Clinics offered by Mercy Springfield and Cox Health Systems treated a total of 300 people Saturday. Each also ran clinics Sunday in the aftermath of an exposure at the Red Robin restaurant in Springfield this month. On Monday, vaccinations will be available from noon to 4 at: Mercy’s urgent care at the Smith Glynn Callaway building at 3231 S. National Avenue and Cox’s urgent care at the Turner Center at 1000 E. Primrose. On Tuesday, the health…
  • Red Robin Hit with another Hepatitis A Problem

    Bill Marler
    24 May 2014 | 8:27 am
    The Springfield-Greene County Health Department administered 2,011 vaccines during a two-day, no-cost clinic on May 22 and 23 to protect the public against a possible Hepatitis A exposure. On May 20, health department officials learned of an individual who had tested positive for Hepatitis A. After learning that individual was a food service worker at the local Red Robin restaurant, department leadership decided to alert the public out of an abundance of caution.
Individuals potentially exposed to the Hepatitis A virus dined at the restaurant between May 8 and 16. The department organized…
  • Red Robin Reports Hepatitis A Worry

    Bill Marler
    7 May 2014 | 1:09 pm
    The Pocono Record reports that the Pennsylvania Department of Health is investigating a situation involving a Red Robin restaurant employee who was diagnosed with Hepatitis A. “The Disease Prevention and Control Law prohibits us from providing further details as the investigation is ongoing at this time,” said Aimee Tysarczyk, press secretary/director of communications for the state Health Department.  “As the investigation continues and if any public health risks evolve, the department will provide additional information to ensure the safety and well-being of the public, as needed,”…
 
  • add this feed to my.Alltop

    HCV New Drug Research

  • July Newsletters: 5 Things to Know About Hepatitis C, Sofosbuvir Cost, 2014 Drug Guide, and More...

    11 Jul 2014 | 7:41 am
    July Newsletters: 5 Things to Know About Hepatitis C, Sofosbuvir Cost, 2014 Drug Guide, and More...Hello folks, welcome to this months newsletters and updates. Before we get started I have a bit of news to share. Over the course of the next few weeks I will be cruising northern Europe with my youngest son! I can't wait!We will be visiting Baltic cities like Copenhagen, Stockholm, Helsinki, and Germany, with overnight calls in Russia's St. Petersburg. Last month I had the pleasure of traveling to Alaska with my eldest son, here we are atop the Mendenhall glacier.Although I am excited to…
  • Factors Influencing Adherence in Hepatitis-C Infected Patients

    11 Jul 2014 | 6:56 am
    Factors Influencing Adherence in Hepatitis-C Infected PatientsA Systematic ReviewTim Mathes, Sunya-Lee Antoine, Dawid PieperBMC Infect Dis. 2014;14(203) Abstract Background: Adherence is a crucial point for the successful treatment of a hepatitis-C virus infection. Studies have shown that especially adherence to ribavirin is important. The objective of this systematic review was to identify factors that influence adherence in hepatitis-C infected patients taking regimes that containing ribavirin. Methods: A systematic literature search was performed in Medline and Embase in March 2014…
  • Vermont - Number of Hepatitis C cases second only to Lyme disease in 2013

    10 Jul 2014 | 8:46 am
    Number of Hepatitis C cases second only to Lyme disease in 2013  By Laura KrantzMore than 600 Vermonters have chronic hepatitis C. The disease was the second most commonly tracked by public health officials last year, according to data from the Vermont Department of Health.The Health Department began monitoring hepatitis C data in the past three months, to look for trends and see if doctors are performing duplicate tests for the virus.Meanwhile, taxpayer-funded health insurance programs for poor and older Vermonters, who are more likely to have hepatitis C, cover the new treatment drug…
  • Validation of the fatigue severity scale in chronic hepatitis C

    9 Jul 2014 | 7:56 am
    Validation of the fatigue severity scale in chronic hepatitis CThe complete text article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.Kathleen Rosa, Min Fu, Leen Gilles, Karin Cerri, Monika Peeters, Jeffrey Bubb and Jane Scott Health and Quality of Life Outcomes 2014, 12:90 doi:10.1186/1477-7525-12-90Published: 11 June 2014Abstract (provisional)BackgroundFatigue is a common symptom of chronic hepatitis C virus (cHCV) infection and a common side effect of interferon-based treatment for cHCV. This study provides confirmatory evidence of the…
  • Hepatitis C - Transmission of the virus following antiviral treatment

    8 Jul 2014 | 3:34 pm
    Transmission of hepatitis C virus following antiviral treatment July 8, 2014 Millions of people throughout the world are infected with hepatitis C virus (HCV). Left untreated, infection results in serious complications such as cirrhosis of the liver and cancer. Many HCV-infected patients respond well to anti-viral therapy and remain virus free. However, trace amounts of HCV RNA are sporadically detected in patients thought to have successfully responded to HCV treatment. A recent study in the Journal of Clinical Investigation tested if this reappearing HCV RNA is infectious. Using an animal…
Log in